Paxlovid antiviral therapy reduces risk of long COVID

A network of molecules and atoms of glass and crystals constitute a single system. 3D illustration

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

Combining chemotherapy with an inflammation inhibitor can prevent breast cancer metastasis

Previous article

Ready to shop? These are the best Walmart Black Friday deals you can buy right now.

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News